Journal
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
Volume 33, Issue 4, Pages 331-337Publisher
CAMBRIDGE UNIV PRESS
DOI: 10.1086/664755
Keywords
-
Funding
- Pfizer
- AstraZeneca
Ask authors/readers for more resources
Antimicrobial stewardship programs attempt to optimize prescribing of these drugs to benefit both current and future patients. Recent regulatory and other incentives have led to widespread adoption of such programs. Measurements of the success of these programs have focused primarily on process measures. However, evaluation of outcome measures will be needed to ensure sustainability of these efforts. Outcome efforts to date provide some evidence for improved care of individual patients, some evidence for minimizing emergence of resistance, and ample evidence for cost reduction. Attention to evaluation methods must be increased to provide convincing evidence for the continuation of such programs. Infect Control Hosp Epidemiol 2012; 33(4): 331-337
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available